HilleVax EBIT

HilleVax (HLVX) currently reports a EBIT of $-74M as of June 2025. That compares with $-140M in the prior-year period — up 48.8% year over year. That is below the sector sector average of $-26M. Use the charts on this page to explore HilleVax's EBIT history and peer comparisons.

HilleVax's EBIT increased from $-140M to $-74M — a 48.8% year-over-year increase (period ending June 2025). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

HilleVax's EBIT of $-74M is lower than the its sector sector average of $-26M. That is roughly 184.7% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

HilleVax reported $-74M in EBIT as of June 2025. That compares with $-140M in the prior-year period — up 48.8% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current EBIT of $-74M, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is $-26M. From there, open related valuation or income-statement pages for HilleVax, and consider following HLVX for alerts when major investors trade the stock.